Tag: Drug development updates
Alzheimer’s Drug Reversal & Bavarian Nordic’s Trump Views: Pharmalittle Update
As the week comes to an end, it's time to start thinking about weekend plans. Whether it's tidying up, taking a trip to see...
Pharmalittle: Updates on Charles River Monkey Shipments and VC Partners in China
Good day to you! The sun is shining, the birds are singing, and the Pharmalot campus is buzzing with activity. We're starting our day...
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news....
Bavarian Nordic’s MPOX Shot and Ozempic Prescribing Crackdown: Pharmalittle Updates
Bavarian Nordic's MPOX Shot and Ozempic Prescribing Crackdown: Pharmalittle UpdatesAs we approach the end of another workweek, it's time to start thinking about weekend...
Wegovy Study Results and Alnylam Heart Drug: Pharmalittle Update
Novo Nordisk's obesity drug Wegovy has shown promising results in a new analysis that could potentially expand its label for the treatment of heart...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
